References to the "Company," "us," "our" or "we" refer to Mission Advancement
Corp. The following discussion and analysis of our financial condition and
results of operations should be read in conjunction with our audited financial
statements and related notes included herein.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Report
including, without limitation, statements under this "Management's Discussion
and Analysis of Financial Condition and Results of Operations" regarding the
Company's financial position, business strategy and the plans and objectives of
management for future operations, are forward- looking statements. When used in
this Report, words such as "anticipate," "believe," "estimate," "expect,"
"intend" and similar expressions, as they relate to us or the Company's
management, identify forward-looking statements. Such forward-looking statements
are based on the beliefs of management, as well as assumptions made by, and
information currently available to, the Company's management. Actual results
could differ materially from those contemplated by the forward- looking
statements as a result of certain factors detailed in our filings with the SEC.
All subsequent written or oral forward-looking statements attributable to us or
persons acting on the Company's behalf are qualified in their entirety by this
paragraph.
The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the financial statements and the
notes thereto contained elsewhere in this Report. Certain information contained
in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.
Overview
We are a Delaware corporation structured as a blank check company formed for the
purpose of effecting our initial business combination with one or more
businesses. We intend to effectuate our initial business combination using cash
from the proceeds of the initial public offering and the sale of the private
placement warrants, our capital stock, debt or a combination of cash, stock and
debt. We are an emerging growth company and, as such, the Company is subject to
all of the risks associated with emerging growth companies.
We expect to continue to incur significant costs in the pursuit of our
acquisition plans. We cannot assure you that our plans to raise capital or to
complete our initial business combination will be successful.
Results of Operations and Known Trends or Future Events
We have neither engaged in any operations nor generated any revenues to date.
Our only activities since inception have been organizational activities, those
necessary to prepare for our initial public offering and identifying a target
company for our initial business combination. We do not expect to generate any
operating revenues until after completion of our initial business combination.
We generate non-operating income in the form of interest income on cash and cash
equivalents held in the trust account. We incur expenses as a result of being a
public company (for legal, financial reporting, accounting and auditing
compliance), as well as for due diligence expenses.
For the year ended December 31, 2021, we had a net income of $11,066,748. We
incurred $2,288,173 of formation and operating costs consisting mostly of
general and administrative expenses and offering expense related to warrants of
$864,511. We had investment income of $18,988 on our amounts held in the trust
account and change in fair value of warrant liabilities of $14,200,444.
For the period from December 22, 2020 (Inception) to December 31, 2020, we had a
net loss of $761. We incurred $761 of formation and operating costs consisting
mostly of general and administrative expenses.
22
We reclassified a portion of the offering costs associated with the initial
public offering originally charged to stockholders' equity, to an expense in the
statement of operations in the amount of $864,511 based on a relative fair value
basis. The change in fair value of warrants was a decrease in the liability of
$14,200,444 and $0, respectively, for the years ended December 31, 2021 and
December 31, 2020.
Liquidity and Capital Resources
As of December 31, 2021, we had cash outside the trust account of $612,101
available for working capital needs. All remaining cash held in the trust
account is generally unavailable for the Company's use, prior to an initial
business combination, and is restricted for use either in a business combination
or to redeem common stock. As of December 31, 2021, none of the amount in the
trust account was available to be withdrawn as described above.
Through December 31, 2021, the Company's liquidity needs were satisfied through
receipt of $25,000 from the sale of the founder shares, and the remaining net
proceeds from the initial public offering and the sale of private placement
warrants.
On December 1, 2021, we issued the Promissory Note to our sponsor in the
principal amount of up to $1,500,000. The Promissory Note was issued in
connection with advances the sponsor has made, and may make in the future, to us
for working capital expenses. As of December 31, 2021, the outstanding balance
of the Promissory Note was $550,000. See "Conversion Feature of Promissory Note"
below and "Item 13. Certain Relationships and Related Transactions, and Director
Independence" for more information regarding the Promissory Note.
Going Concern
The Company anticipates that the $612,101 outside of the trust account as of
December 31, 2021, might not be sufficient to allow the Company to operate until
March 5, 2023, the period it has to consummate an initial business combination,
assuming that a business combination is not consummated during that time. Until
consummation of our business combination, the Company will be using the funds
not held in the trust account, and any additional Working Capital Loans (as
defined in Note 6 to our financial statements) from the initial stockholders,
the Company's officers and directors, or their respective affiliates (which is
described in Note 6 to our financial statements), for identifying and evaluating
prospective acquisition candidates, performing business due diligence on
prospective target businesses, traveling to and from the offices, plants or
similar locations of prospective target businesses, reviewing corporate
documents and material agreements of prospective target businesses, selecting
the target business to acquire and structuring, negotiating and consummating the
business combination.
The Company can raise additional capital through Working Capital Loans from the
initial stockholders, the Company's officers, directors, or their respective
affiliates (which is described in Note 6 to our financial statements) or through
loans from third parties. None of the sponsor, officers or directors are under
any obligation to advance funds to, or to invest in, the Company. If the Company
is unable to raise additional capital, it may be required to take additional
measures to conserve liquidity, which could include, but not necessarily be
limited to, curtailing operations, suspending the pursuit of its business plan,
and reducing overhead expenses. The Company cannot provide any assurance that
new financing will be available to it on commercially acceptable terms, if at
all. These conditions raise substantial doubt about the Company's ability to
continue as a going concern for a reasonable period of time, which is considered
to be one year from the issuance date of the financial statements.
The Company has until March 5, 2023, 24 months from the closing of the initial
public offering, to consummate a business combination (the "Combination
Period"). However, if the Company is unable to complete a business combination
within the Combination Period, the Company will redeem 100% of the outstanding
public shares for a pro rata portion of the funds held in the trust account,
equal to the aggregate amount then on deposit in the trust account including
interest earned on the funds held in the trust account and not previously
released to the Company, divided by the number of then outstanding public
shares, subject to applicable law and as further described in the registration
statement, and then seek to dissolve and liquidate. There is a possibility that
a business combination might not happen within the Combination Period.
Off-Balance Sheet Financing Arrangements
As of December 31, 2021, we did not have any off-balance sheet arrangements as
defined in Item 303(a)(4)(ii) of Regulation S-K. We do not participate in
transactions that create relationships with unconsolidated entities or financial
partnerships, often referred to as variable interest entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of
other entities, or purchased any non-financial assets.
23
Contractual Obligations
As of December 31, 2021, we did not have any long-term debt, capital or
operating lease obligations.
We entered into an administrative support agreement pursuant to which we pay our
sponsor for office space and secretarial and administrative services provided to
members of our management team, in an amount not to exceed $10,000 per month.
Since March 5, 2021, we have paid the sponsor a total of $10,000 per month for
office space and administrative support services. Upon completion of the initial
business combination or our liquidation, we will cease paying these monthly
fees. We incurred $99,677 in such fees in the year ended December 31, 2021.
Critical Accounting Estimates
We do not use derivative instruments to hedge exposures to cash flow, market, or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to the
Financial Accounting Standard Board's ("FASB") Accounting Standards Codification
("ASC") Topic 480 "Distinguishing Liabilities from Equity" and ASC Topic 815-15.
The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is reassessed at the end of each
reporting period.
Derivative Warrant Liabilities
We issued an aggregate of 17,433,333 warrants in connection with our initial
public offering and private placement, which, are recognized as derivative
liabilities in accordance with ASC Topic 815-40. Accordingly, we recognize the
warrants as liabilities at fair value and adjust the instruments to fair value
at each reporting period. The liabilities are subject to remeasurement at each
balance sheet date until exercised, and any change in fair value is recognized
in the Company's statement of operations. At initial public offering, the
Company utilized a Monte Carlo simulation model to determine the initial value
of the public warrants and private warrants. At December 31, 2021, the Company
used the quoted stock price in the active market to value the public warrants
and a Monte Carlo simulation model to value the private warrants with changes in
fair value charged to the statement of operations.
Conversion Feature of Promissory Note
On December 1, 2021, we issued the Promissory Note to our sponsor. The
Promissory Note was issued in connection with advances the sponsor has made, and
may make in the future, to us for working capital expenses. The lender may elect
to convert up to $1,500,000 of the unpaid principal balance of the Promissory
Note into warrants, each warrant exercisable for one share of our Class A common
stock upon the consummation of an initial business combination. This embedded
conversion feature is subject to remeasurement at each balance sheet date until
exercised, and any change in fair value is recognized in the Company's statement
of operations. It is valued using the Geske compound valuation model and at both
issuance date and December 31, 2021, its value was de minimis.
Recent Accounting Standards
In August 2020, the FASB issued Accounting Standard Update ("ASU") Topic
2020-06, "Debt-Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity's Own Equity"
("ASU 2020-06"), which simplifies accounting for convertible instruments by
removing major separation models required under current GAAP. ASU 2020-06 also
removes certain settlement conditions that are required for equity-linked
contracts to qualify for scope exception, and it simplifies the diluted earnings
per share calculation in certain areas. The Company adopted ASU 2020-06 on
January 1, 2021. Adoption of ASU 2020-06 did not impact the Company's financial
position, results of operations or cash flows.
The Company's management does not believe that any other recently issued, but
not yet effective, accounting standards if currently adopted would have a
material effect on the accompanying financial statements.
Factors That May Adversely Affect Our Results of Operations
Our results of operations and our ability to complete an initial business
combination may be adversely affected by various factors that could cause
economic uncertainty and volatility in the financial markets, many of which are
beyond our control. Our business could be impacted by, among other things,
downturns in the financial markets or in economic conditions, increases in oil
prices, inflation, increases in interest rates, supply chain disruptions,
declines in consumer confidence and spending, the ongoing effects of the
COVID-19 pandemic, including resurgences and the emergence of new variants, and
geopolitical instability, such as the military conflict in the Ukraine. We
cannot at this time fully predict the likelihood of one or more of the above
events, their duration or magnitude or the extent to which they may negatively
impact our business and our ability to complete an initial business combination.
© Edgar Online, source Glimpses